| Issue | Title | |
| Vol 1, Issue 2 (2021) | Efficiency and safety of the author's method of wrist tapping as a personalized method of emergency self-help in focal epilepsy | Abstract PDF (Eng) |
| E. A. Narodova, V. V. Narodova, K. V. Petrov, A. V. Yakunina, I. E. Poverennova | ||
| Vol 2, Issue 1 (2022) | Epidemiology of Amyotrophic Lateral Sclerosis | Abstract PDF (Eng) |
| P. S. Goncharova, T. K. Davidova, N. A. Shnayder, M. A. Novitsky, R. F. Nasyrova | ||
| Vol 6, Issue 3 (2026) | Epigenetic Biomarkers of Cardiogenic Cognitive Disorder in a Rat Model of Myocardial Infarction (Part 1) | Abstract PDF (Eng) |
| Aleksandr A. Evsyukov, N. A. Shnayder, Marina M. Petrova, Natalia A. Malinovskaya, Diana V. Dmitrenko, Artem V. Petrov, Anastasia A. Vasilieva, Daria V. Fadeeva, Anna S. Artemeva, Elena E. Timechko, Anastasia I. Paramonova | ||
| Vol 5, Issue 2 (2025) | Evolution of the Concept of Treatment-Resistant Schizophrenia | Abstract PDF (Eng) |
| Anna S. Shumilova, Alla V. Kidyaeva, Regina F. Nasyrova | ||
| Vol 6, Issue 1 (2026) | Frequencies of ABCB1 Gene Variant Alleles and Their Role in Response to Antipsychotic Therapy in Patients with Schizophrenia Spectrum Disorders: Narrative Review | Abstract PDF (Eng) |
| Natalia A. Shnayder, Ekaterina I. Glushchenko, Anastasia A. Abramenko, Evgeniya K. Kaisinova, Asiyat M. Shirukova, Ilya L. Glushchenko, Regina F. Nasyrova | ||
| Vol 4, Issue 3 (2024) | Frequency of "Poor Transporter" Phenotype Among Patients with Mental Disorders: Pilot Study | Abstract PDF (Eng) |
| I. R. Boyko, N. A. Shnayder, V. V. Grechkina, O. E. Savelieva | ||
| Vol 2, Issue 1 (2022) | From Classical to Personalized Psychoneurology | Abstract PDF (Eng) |
| N. G. Neznanov, R. F. Nasyrova, N. A. Shnayder | ||
| Vol 5, Issue 1 (2025) | Gender Characteristics of Anxiety: Brief Review | Abstract PDF (Eng) |
| N. Yu. Safonova, L. V. Lukina | ||
| Vol 6, Issue 1 (2026) | Gene and Cell Technologies for Personalized Medicine | Abstract PDF (Eng) |
| Albert A. Rizvanov | ||
| Vol 3, Issue 1 (2023) | Generalized Anxiety Disorder Therapy, Associated with Pronounced Side Effects, and Prospects for the Use of Pharmacogenetic Testing: Case report | Abstract PDF (Eng) |
| A. I. Strelnik, D. V. Romanov, S. N. Strelnik | ||
| 41 - 50 of 129 Items | << < 1 2 3 4 5 6 7 8 9 10 > >> | |
Browse Title Index
Popular articles
Vol 2, Issue 1 (2022)
Vol 1, Issue 1 (2021)
Vol 1, Issue 1 (2021)
Vol 1, Issue 1 (2021)
Vol 1, Issue 1 (2021)
Keywords
Parkinson's disease
adverse drug reaction
adverse drug reactions
adverse reaction
antipsychotic
antipsychotics
biomarkers
candidate genes
clozapine
efficacy
epilepsy
genetics
long QT syndrome
metabolic syndrome
personalized medicine
pharmacogenetic testing
pharmacogenetics
safety
schizophrenia
single nucleotide variant
therapeutic resistance
3, Bekhterev street, bldg. 6, 192019, Saint-Petersburg, Russian Federation
Telephone: +7 (812) 670 02 20, add. 7813, 7814
E-mail: journal.ppnn@gmail.com
